Mergers & Acquisitions
Representations and Warranties Insurance: What a Selling Founder Still Carries
Representations and warranties insurance moves most of the risk that your reps turn out to be wrong off your escrow and onto an insurer. It is now ordinary rather than exotic: a policy was identified on approximately 46% of the 2025 private-target deals in SRS Acquiom's 2026 study of more than 2,300 transactions (2026 M&A Deal Terms Study). What it does not do is end a seller's exposure.
A policy carries a retention that the seller often funds half of, a list of exclusions that includes the purchase price adjustment, and no cover at all for anything diligence has already turned up. The question worth your attention is not whether to accept a policy when the buyer proposes one. It is which risks the policy declines, and where those land when it does.
The policy sits where the escrow used to sit
Most of these are buy-side policies: the buyer is the insured, and the insurer pays the buyer for a breach of the seller's representations instead of the buyer reaching into a holdback (Koley Jessen). The seller's benefit is indirect and it is the whole point: with an insurer standing behind the reps, the buyer has less reason to demand that a large share of the price sit in escrow for a year or two.
The size difference is not marginal. Among 2025 deals in the SRS Acquiom study that carried an indemnification escrow, deals where the buyer bought a policy held back a median of 0.5% of transaction value, against a median of 10.0% where no policy was identified. On averages the gap was 2.2% against 11.3%.
That is the trade a founder is actually being offered: a smaller amount of your own money held hostage to a claim that may never come, in exchange for accepting a structure whose edges are defined by an insurance contract you are not a party to.
Eligibility starts around $10 million of enterprise value
The first question is whether the product is available on your deal at all. Gallagher's published overview of the coverage, written for financial-institution deals, says the broker typically recommends it for targets with an enterprise value of $10 million to $20 billion, and that the market now supports smaller deals as well (Gallagher). Koley Jessen's guide sets the practical line higher, describing the coverage as generally reserved for deals of at least $20 million to $30 million. For a founder selling in the lower middle market, that floor is the line between a real option and a conversation about escrow, and it is worth establishing early — alongside what the price itself is built on.
The same overview describes the economics: a one-time premium of roughly 3% to 4% of the coverage limit with a minimum around $80,000; a retention of roughly 0.5% to 0.75% of transaction value with a minimum around $150,000, usually split half to the buyer's deductible and half to a seller indemnity or escrow; and that retention dropping to roughly 0.3% to 0.5% twelve months after closing. Who pays the premium is negotiated: Koley Jessen's guide says the buyer often bears it or it is split, and that the seller may be asked to pay it.
What representations and warranties insurance does not cover
Four categories do most of the work, and three of them are the ones that surprise sellers.
Purchase price adjustments. The working capital true-up is outside the policy. Whatever the closing accounts produce is settled between buyer and seller under the purchase agreement, not by an insurer, and the sum involved is often larger than the retention.
Known issues. Anything disclosed on the schedules, identified in diligence, or surfaced during underwriting is excluded. So is a "known unknown" — a problem everyone can see whose cost nobody can yet size.
Covenants and forward-looking statements. Projections, budgets and the seller's promises about conduct between signing and closing are not representations about present fact, and the policy does not treat them as covered.
Deal-specific exclusions. The underwriter reads the diligence reports and adds carve-outs for whatever it does not want. That list is not standard; it is produced by the underwriting on your transaction.
The retention, the excluded items and fraud stay with the seller
A "no seller indemnity" deal is rarely zero. What typically remains is a strip indemnity or a share of the retention, and potential exposure for what the policy excludes. Koley Jessen's guide describes buy-side policies as generally waiving the insurer's right of subrogation against the seller except in cases of fraud, and calls that a key point to confirm.
Read that carve-out carefully rather than as boilerplate. It means the insurer's forbearance toward the seller ends if fraud is alleged, and how "fraud" is defined in the purchase agreement and in the policy decides how much room that leaves. Circumstances differ, and the wording in a specific deal is what governs it.
A hypothetical sale, and where the money actually sits
The following is constructed and hypothetical. It is not any company's facts.
Assume a founder-owned company selling for $30 million, with a $3 million policy limit. At 0.75% of transaction value, the retention is $225,000; split evenly, the seller escrows $112,500 and the buyer absorbs the rest, and the retention steps down to $150,000 after twelve months. The premium at 3% to 4% of the limit runs $90,000 to $120,000, paid once.
Set that against the alternative. At the 2025 medians in the SRS Acquiom study, an indemnification escrow on a deal with no policy would be 10.0% of transaction value — $3 million of the price sitting in escrow — against 0.5%, or $150,000, on a deal with a policy.
Now the part the structure does not solve. If the closing accounts come in $400,000 light on working capital, that is a purchase price adjustment, and it lands on the seller in full regardless of the policy. If diligence flagged an unresolved sales tax position and it was disclosed, the exposure stays with the seller. The founder who read "no indemnity" and stopped reading has $112,500 escrowed, $400,000 of true-up, and an uninsured tax question.
The disclosure schedules decide what the policy leaves behind
Because known issues are excluded, every item a seller discloses is an item the insurer will not pay for. That does not make disclosure optional — inaccurate schedules create the exact breach the policy is being bought to cover, and the fraud carve-out sits behind it. What it means is that the schedules stop being a compliance chore and become the map of what the seller keeps.
The practical consequence is that the schedules and the diligence responses should be built before the underwriter sees them, not after. What a buyer tests in diligence is a reasonable proxy for what an underwriter will ask about.
Timing follows from that. Gallagher's overview puts placement at seven to fourteen days from submission of the documentation and recommends engaging the broker about four weeks before signing. Four weeks before signing is inside the exclusivity period, which is to say it sits in the window the letter of intent already governs — and your negotiating position in that window is weaker than it was the week before you signed the LOI.
If a buyer has raised a policy on your deal, the useful next step is to price what you keep rather than what you are relieved of: the retention split, the exclusion list as underwritten, and the fraud definition. If a second read on that would help, our mergers and acquisitions practice is glad to look.
Disclaimer. This publication is provided by Amini & Conant, LLP for educational and informational purposes only and is not intended and should not be construed as legal advice. Should the reader seek further analysis of the subject matter or answers to specific questions about the subject matter, please contact the author at neema@aminiconant.com. This publication is considered advertising under applicable state laws.